Loading...
XSHE300381
Market cap443mUSD
Jan 09, Last price  
6.77CNY
1D
-0.15%
1Q
0.59%
Jan 2017
-71.70%
IPO
-8.02%
Name

Guangdong VTR Bio-Tech Co Ltd

Chart & Performance

D1W1MN
XSHE:300381 chart
P/E
—
P/S
4.08
EPS
—
Div Yield, %
1.57%
Shrs. gr., 5y
3.83%
Rev. gr., 5y
-14.75%
Revenues
796m
-32.20%
85,691,585147,241,060179,871,044216,863,387270,454,522337,425,697359,159,329359,816,415703,472,7171,512,440,9921,499,263,3221,768,167,8082,048,133,4041,914,764,4581,892,160,3361,174,006,689796,021,979
Net income
-11m
L
11,507,25219,511,73824,486,13928,184,23343,176,16554,714,63963,134,79355,122,79171,829,414113,566,05980,424,345113,508,486127,522,059161,706,004018,232,003-10,749,720
CFO
154m
-38.18%
0025,638,50035,345,07553,500,47061,319,05067,911,39817,959,69154,158,88500203,948,204442,165,361403,726,106216,929,263249,773,827154,399,928
Dividend
Jun 18, 20240.06 CNY/sh
Earnings
May 15, 2025

Profile

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.
URL
http://www.yiduoli.com
IPO date
Jan 28, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
796,022
-32.20%
1,174,007
-37.95%
Cost of revenue
765,597
1,144,333
Unusual Expense (Income)
NOPBT
30,425
29,673
NOPBT Margin
3.82%
2.53%
Operating Taxes
127
67,548
Tax Rate
0.42%
227.64%
NOPAT
30,298
(37,875)
Net income
(10,750)
-158.96%
18,232
 
Dividends
(51,063)
(49,007)
Dividend yield
1.41%
1.33%
Proceeds from repurchase of equity
(39,062)
(1)
BB yield
1.08%
0.00%
Debt
Debt current
74,465
100,238
Long-term debt
115
51,527
Deferred revenue
44,436
49,997
Other long-term liabilities
820
1
Net debt
(604,471)
(1,409,706)
Cash flow
Cash from operating activities
154,400
249,774
CAPEX
(394,166)
Cash from investing activities
142,216
Cash from financing activities
(214,251)
76,873
FCF
(115,884)
1,752,250
Balance
Cash
1,232,858
1,561,471
Long term investments
(553,806)
Excess cash
639,251
1,502,771
Stockholders' equity
1,227,078
1,268,766
Invested Capital
2,215,619
1,738,960
ROIC
1.53%
ROCE
1.06%
0.98%
EV
Common stock shares outstanding
490,855
483,650
Price
7.37
-3.28%
7.62
-35.80%
Market cap
3,617,600
-1.84%
3,685,411
-36.65%
EV
3,133,746
2,385,678
EBITDA
142,516
167,942
EV/EBITDA
21.99
14.21
Interest
3,467
19,761
Interest/NOPBT
11.40%
66.60%